HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
$193.03
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$193.03
Sarado: Dis 12, 6:11:01 PM GMT-5 · USD · NYSE · Disclaimer
Nakaraang pagsara
$194.43
Sakop ng araw
$192.09 - $195.51
Sakop ng taon
$91.86 - $199.66
Market cap
9.50B USD
Average na Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.00B | -0.49% |
Gastos sa pagpapatakbo | 193.65M | -9.43% |
Net na kita | 54.42M | -21.87% |
Net profit margin | 5.42 | -21.45% |
Kita sa bawat share | 2.43 | -6.18% |
EBITDA | 172.65M | -28.70% |
Aktuwal na % ng binabayarang buwis | 36.29% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 207.10M | -1.46% |
Kabuuang asset | 7.51B | -6.12% |
Kabuuang sagutin | 4.06B | -2.71% |
Kabuuang equity | 3.45B | — |
Natitirang share | 49.22M | — |
Presyo para makapag-book | 2.81 | — |
Return on assets | 5.26% | — |
Return on capital | 6.46% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 54.42M | -21.87% |
Cash mula sa mga operasyon | 213.83M | -15.08% |
Cash mula sa pag-invest | -33.70M | -58.02% |
Cash mula sa financing | -152.62M | 26.46% |
Net change in cash | 24.48M | -20.09% |
Malayang cash flow | 65.54M | -71.13% |
Tungkol
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Itinatag
1947
Headquarters
Website
Mga Empleyado
19,400